Hauptseite
Ausbildung

Introduction to Liposomes in Anti-cancer Therapy

Daten

Offizielle Daten in der Fachveröffentlichung für das folgende akademische Jahr: 2023-2024

Lehrbeauftragte/r

  • Sourav DAS

    assistant lecturer,
    Institute of Pharmaceutical Technology and Biopharmacy

Semesterwochenstunden

Vorlesungen: 28

Praktika: 0

Seminare: 0

Insgesamt: 28

Fachangaben

  • Kode des Kurses: OXF-LAC-g-T
  • 2 kredit
  • Pharmacy
  • Optional modul
  • autumn
Voraussetzungen:

OGG-C4E-T completed , OGG-D3E-T parallel

Zahl der Kursteilnehmer für den Kurs:

min. 5 – max. 30

Erreichbar als Campus-Kurs für 30 fő számára. Campus-karok: ÁOK ETK GYTK TTK

Thematik

The course provides introductory knowledge to the subject area of liposome-based nano-formulations for targeted drug delivery systems in cancer therapy. Throughout the semester, the most important basic knowledge will be based on novel liposomal anticancer drug delivery strategies. The students will receive insight into the professional background of liposome drug delivery systems for anticancer treatments, mode of action, challenges, and current clinical trial status of the novel liposomal-anticancer drug candidates.

Vorlesungen

  • 1. Introduction - Dr. Das Sourav
  • 2. Introduction - Dr. Das Sourav
  • 3. Applications of liposomes in cancer therapeutics - Dr. Das Sourav
  • 4. Applications of liposomes in cancer therapeutics - Dr. Das Sourav
  • 5. Liposome preparation - Dr. Das Sourav
  • 6. Liposome preparation - Dr. Das Sourav
  • 7. Sensitivity enhancement of liposomes and its therapeutic usage - Dr. Das Sourav
  • 8. Sensitivity enhancement of liposomes and its therapeutic usage - Dr. Das Sourav
  • 9. Modes of administration of liposomal drugs I - Dr. Das Sourav
  • 10. Modes of administration of liposomal drugs I - Dr. Das Sourav
  • 11. Modes of administration of liposomal drugs II - Dr. Das Sourav
  • 12. Modes of administration of liposomal drugs II - Dr. Das Sourav
  • 13. Liposomes-mediated targeted drug delivery and its mode of action - Dr. Das Sourav
  • 14. Liposomes-mediated targeted drug delivery and its mode of action - Dr. Das Sourav
  • 15. Liposomal gels for drug delivery - Dr. Das Sourav
  • 16. Liposomal gels for drug delivery - Dr. Das Sourav
  • 17. Liposomes as versatile carriers for dual drug loading - Dr. Das Sourav
  • 18. Liposomes as versatile carriers for dual drug loading - Dr. Das Sourav
  • 19. Clinical trials and FDA-approved liposomal nanoformulations as anticancer agents - Dr. Das Sourav
  • 20. Clinical trials and FDA-approved liposomal nanoformulations as anticancer agents - Dr. Das Sourav
  • 21. Challenges and limitations in liposomal drug delivery strategies - Dr. Das Sourav
  • 22. Challenges and limitations in liposomal drug delivery strategies - Dr. Das Sourav
  • 23. Future prospectives - Dr. Das Sourav
  • 24. Future prospectives - Dr. Das Sourav
  • 25. Research paper findings and case studies - Dr. Das Sourav
  • 26. Research paper findings and case studies - Dr. Das Sourav
  • 27. The report and written exam - Dr. Das Sourav
  • 28. The report and written exam - Dr. Das Sourav

Praktika

Seminare

Materialien zum Aneignen des Lehrstoffes

Obligatorische Literatur

Vom Institut veröffentlichter Lehrstoff

Literature developed by the Department.

Skript

Notes

Empfohlene Literatur

Class notes and materials issued during the semester.

Voraussetzung zum Absolvieren des Semesters

Maximum of 25 % absence allowed

Semesteranforderungen

Students have to write an end-semester assessment from the lecture at an acceptable level of 60%.

Möglichkeiten zur Nachholung der Fehlzeiten

In case absences exceed 25% of total class time, the course will be regarded as uncompleted. There is no opportunity to make up missed classes.

Prüfungsfragen

Students have to write an end-semester assessment from the lecture at an acceptable level of 60%.

Prüfer

Praktika, Seminarleiter/innen

Rólunk